NDC Compounded Drug 70214-2021-1 Vancomycin
Injection, Solution Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Vancomycin
NDC crossover of Vancomycin 1.5g In 250ml with NDC 70214-2021 a human compounded drug with other similar products matching the same substance name (Vancomycin) and the same administration route (intravenous) or dosage form (injection, solution).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 70214-2020-1 | Vancomycin 1.25g In 250ml | Vancomycin | 250 mL in 1 BAG | Injection, Solution | Intravenous | Providence Infusion Hospital Services |
| 70214-2020-1 | Vancomycin 1.25g In 250ml | Vancomycin | 250 mL in 1 BAG | Injection, Solution | Intravenous | Providence Infusion Hospital Services |
| 70214-2020-1 | Vancomycin 1.25g In 250ml | Vancomycin | 250 mL in 1 BAG | Injection, Solution | Intravenous | Providence Infusion Hospital Services |
| 70214-2020-1 | Vancomycin 1.25g In 250ml | Vancomycin | 250 mL in 1 BAG | Injection, Solution | Intravenous | Providence Infusion Hospital Services |
Frequently Asked Questions
What is the NDC number assigned to Vancomycin 1.25g In 250ml?
Vancomycin 1.25g In 250ml was assigned by its manufacturer with NDC product code 70214-2021. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Vancomycin 1.25g In 250ml?
The NDC package code 70214-2021-1 was assigned to a 250 mL in 1 BAG of vancomycin administered intravenous via injection, solution.
Who manufactures this product?
Vancomycin 1.25g In 250ml is manufactured by an outsourced facility and labeled by Providence Infusion Hospital Services. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 4 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by PROVIDENCE INFUSION HOSPITAL SERVICES with NDC product codes 70214-2020-1, 70214-2020-1, 70214-2020-1 and 70214-2020-1.